Literature DB >> 17488448

Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model.

T Kawai1, B J Paster, H Komatsuzawa, C W O Ernst, R B Goncalves, H Sasaki, K Ouhara, P P Stashenko, M Sugai, M A Taubman.   

Abstract

INTRODUCTION: The present study examined whether induction of an adaptive immune response to orally colonizing non-pathogenic Pasteurella pneumotropica by immunization with the phylogenetically closely related bacterium, Actinobacillus actinomycetemcomitans, can result in periodontal bone loss in mice.
METHODS: BALB/c mice harboring P. pneumotropica (P. pneumotropica(+) mice) in the oral cavity or control P. pneumotropica-free mice were immunized with fixed A. actinomycetemcomitans. The animals were sacrificed on day 30, and the following measurements were carried out: (i) serum immunoglobulin G and gingival T-cell responses to A. actinomycetemcomitans and P. pneumotropica; (ii) periodontal bone loss; and (iii) identification of receptor activator of nuclear factor-kappaB ligand (RANKL) -positive T cells in gingival tissue.
RESULTS: Immunization with A. actinomycetemcomitans induced a significantly elevated serum immunoglobulin G response to the 29-kDa A. actinomycetemcomitans outer membrane protein (Omp29), which showed strong cross-reactivity with P. pneumotropica OmpA compared to results in the control non-immunized mice. The A. actinomycetemcomitans-immunized P. pneumotropica(+) mice developed remarkable periodontal bone loss in a RANKL-dependent manner, as determined by the abrogation of bone loss by treatment with osteoprotegerin-Fc. The T cells isolated from the gingival tissue of A. actinomycetemcomitans-immunized P. pneumotropica(+) mice showed an in vitro proliferative response to both A. actinomycetemcomitans and P. pneumotropica antigen presentation, as well as production of soluble(s)RANKL in the culture supernatant. Double-color confocal microscopy demonstrated that the frequency of RANKL(+) T cells in the gingival tissue of A. actinomycetemcomitans-immunized P. pneumotropica(+) mice was remarkably elevated compared to control mice.
CONCLUSION: The induction of an adaptive immune response to orally colonizing non-pathogenic P. pneumotropica results in RANKL-dependent periodontal bone loss in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488448     DOI: 10.1111/j.1399-302X.2007.00348.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  19 in total

1.  Antibody to receptor activator of NF-κB ligand ameliorates T cell-mediated periodontal bone resorption.

Authors:  Xiaoping Lin; Xiaozhe Han; Toshihisa Kawai; Martin A Taubman
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

3.  Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes.

Authors:  Luciana S Branco-de-Almeida; Mikihito Kajiya; Cristina R Cardoso; Marcelo J B Silva; Kouji Ohta; Pedro L Rosalen; Gilson C N Franco; Xiaozhe Han; Martin A Taubman; Toshihisa Kawai
Journal:  FEMS Immunol Med Microbiol       Date:  2011-06-16

4.  NOD2 contributes to Porphyromonas gingivalis-induced bone resorption.

Authors:  T P Prates; T M Taira; M C Holanda; L A Bignardi; S L Salvador; D S Zamboni; F Q Cunha; S Y Fukada
Journal:  J Dent Res       Date:  2014-09-19       Impact factor: 6.116

5.  A novel method of sampling gingival crevicular fluid from a mouse model of periodontitis.

Authors:  Shinji Matsuda; Alexandru Movila; Maiko Suzuki; Mikihito Kajiya; Wichaya Wisitrasameewong; Rayyan Kayal; Josefine Hirshfeld; Ayman Al-Dharrab; Irma J Savitri; Abdulghani Mira; Hidemi Kurihara; Martin A Taubman; Toshihisa Kawai
Journal:  J Immunol Methods       Date:  2016-08-30       Impact factor: 2.303

6.  Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model.

Authors:  Yuta Hamamoto; Kazuhisa Ouhara; Syuichi Munenaga; Mikio Shoji; Tatsuhiko Ozawa; Jyunzo Hisatsune; Isamu Kado; Mikihito Kajiya; Shinji Matsuda; Toshihisa Kawai; Noriyoshi Mizuno; Tsuyoshi Fujita; Shintaro Hirata; Kotaro Tanimoto; Koji Nakayama; Hiroyuki Kishi; Eiji Sugiyama; Hidemi Kurihara
Journal:  Arthritis Res Ther       Date:  2020-10-19       Impact factor: 5.156

7.  Bacteria-reactive immune response may induce RANKL-expressing T cells in the mouse periapical bone loss lesion.

Authors:  Marcelo J B Silva; Mikihito Kajiya; Emad AlShwaimi; Hajime Sasaki; Jennifer Hong; Peter Ok; Taia M B Rezende; Tom C Pagonis; Robert R White; Bruce J Paster; Philip Stashenko; Toshihisa Kawai
Journal:  J Endod       Date:  2012-01-24       Impact factor: 4.171

8.  Platelet-activating factor receptor blockade ameliorates Aggregatibacter actinomycetemcomitans-induced periodontal disease in mice.

Authors:  Mila Fernandes Moreira Madeira; Celso Martins Queiroz-Junior; Graciela Mitre Costa; Silvia Maria Cordeiro Werneck; Daniel Cisalpino; Gustavo Pompermaier Garlet; Mauro Martins Teixeira; Tarcília Aparecida Silva; Daniele G Souza
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

9.  The induced RNA-binding protein, HuR, targets 3'-UTR region of IL-6 mRNA and enhances its stabilization in periodontitis.

Authors:  K Ouhara; S Munenaga; M Kajiya; K Takeda; S Matsuda; Y Sato; Y Hamamoto; T Iwata; S Yamasaki; K Akutagawa; N Mizuno; T Fujita; E Sugiyama; H Kurihara
Journal:  Clin Exp Immunol       Date:  2018-03-08       Impact factor: 4.330

Review 10.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.